Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
257M
-
Number of holders
-
465
-
Total 13F shares, excl. options
-
230M
-
Shares change
-
-4.42M
-
Total reported value, excl. options
-
$27.3B
-
Value change
-
-$519M
-
Put/Call ratio
-
1.57
-
Number of buys
-
222
-
Number of sells
-
-182
-
Price
-
$118.80
Significant Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q4 2014
528 filings reported holding VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock as of Q4 2014.
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) has 465 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 230M shares
of 257M outstanding shares and own 89.49% of the company stock.
Largest 10 shareholders include Capital World Investors (24.6M shares), WELLINGTON MANAGEMENT GROUP LLP (17.2M shares), VANGUARD GROUP INC (15.5M shares), FMR LLC (14.5M shares), PRICE T ROWE ASSOCIATES INC /MD/ (13.3M shares), JPMORGAN CHASE & CO (10.4M shares), State Street Corp (10.3M shares), Ameriprise Financial Inc (9.31M shares), Clearbridge Investments, LLC (7.52M shares), and JENNISON ASSOCIATES LLC (6.71M shares).
This table shows the top 465 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.